The Neuropathology Core (Core D) of the Johns Hopkins Alzheimer's Disease Research Center (ADRC) has two overarching goals, one related to the analysis and distribution of brain tissue and other specimens from subjects in the ADRC, and the other related to the analysis of genetically engineered mouse models by investigators associated with the ADRC.
The specific aims of Core D are as follows: (1) to arrange and perform autopsies on clinically well-characterized subjects enrolled through the JHMI ADRC and assist with consensus diagnoses on subjects associated with the ADRC (comprised of the Clinic Cohort and the BLSA Cohort). (2) to accession and store optimally prepared tissues from the autopsies and to make these specimens available to investigators associated with the ADRC and at other collaborating institutions. (3) to accession and store samples of biological fluids and DNA obtained pre- and postmortem from subjects in the ADRC. (4) to facilitate APOE genotyping on participants in the ADRC. (5) to support the assessment of genetically engineered mouse models relevant to Alzheimer's disease (AD) and related disorders, (6) to collaborate with the medical and research community outside of Johns Hopkins by providing assistance with postmortem diagnoses of AD and other types of dementia, and (7) to train basic investigators and clinical neuroscientists in the morphological and diagnostic concepts relevant to AD, to other types of dementias and neurodegenerative disorders.
The Johns Hopkins Alzheimer's Disease Research Center (ADRC) will address many of the topics important to dementia research, with a particular focus on the understanding the earliest phases of Alzheimer's disease (AD). This approach is important if we are ultimately going to be able to diagnose and treat AD as early as possible. The ADRC fosters interactions among scientists who are pursuing this overarching theme.
|Hibar, Derrek P (see original citation for additional authors) (2017) Novel genetic loci associated with hippocampal volume. Nat Commun 8:13624|
|Haberman, Rebecca P; Koh, Ming Teng; Gallagher, Michela (2017) Heightened cortical excitability in aged rodents with memory impairment. Neurobiol Aging 54:144-151|
|Jeong, Yun Ha; Ling, Jonathan P; Lin, Sophie Z et al. (2017) Tdp-43 cryptic exons are highly variable between cell types. Mol Neurodegener 12:13|
|Weintraub, Sandra; Besser, Lilah; Dodge, Hiroko H et al. (2017) Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord :|
|Rawlings, Andreea M; Sharrett, A Richey; Mosley, Thomas H et al. (2017) Glucose Peaks and the Risk of Dementia and 20-Year Cognitive Decline. Diabetes Care 40:879-886|
|Mori, Susumu; Kageyama, Yusuke; Hou, Zhipeng et al. (2017) Elucidation of White Matter Tracts of the Human Amygdala by Detailed Comparison between High-Resolution Postmortem Magnetic Resonance Imaging and Histology. Front Neuroanat 11:16|
|Valera, Elvira; Spencer, Brian; Mott, Jennifer et al. (2017) MicroRNA-101 Modulates Autophagy and Oligodendroglial Alpha-Synuclein Accumulation in Multiple System Atrophy. Front Mol Neurosci 10:329|
|Brenowitz, Willa D; Keene, C Dirk; Hawes, Stephen E et al. (2017) Alzheimer's disease neuropathologic change, Lewy body disease, and vascular brain injury in clinic- and community-based samples. Neurobiol Aging 53:83-92|
|Gross, Alden L; Hassenstab, Jason J; Johnson, Sterling C et al. (2017) A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortium. Alzheimers Dement (Amst) 8:147-155|
|Liu, Peiying; Li, Yang; Pinho, Marco et al. (2017) Cerebrovascular reactivity mapping without gas challenges. Neuroimage 146:320-326|
Showing the most recent 10 out of 713 publications